Strasbourg, France, June 8, 2017, 6:00 p.m. CET – Transgene’s shareholders held their Combined General Meeting (ordinary and extraordinary) today, chaired by Philippe Archinard, Chairman and CEO, to approve the company financial statements for the year ended December 31, 2016 and to vote on the other resolutions submitted to their approval.
At the Combined General Meeting, the shareholders have:
-renewed the mandates of the following board members Philippe Archinard (who continues as Chairman of the Board), Benoît Habert, Alain Mérieux and TSGH SAS;
-appointed Marie Landel and Maya Saïd as independent board members; and;
-voted the other resolutions submitted, in accordance with the recommendations of the Board of Directors.
...
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer